NovoCure Rlease: Pharma Announces Preliminary Fourth Quarter And Full Year 2016 Operating Statistics

ST. HELIER, Jersey--(BUSINESS WIRE)--Novocure (NASDAQ:NVCR), a commercial-stage oncology company developing a proprietary therapy for solid tumors, will provide a business update as well as its preliminary operating statistics for the fourth quarter and full year 2016 at the 35th Annual J.P. Morgan Healthcare Conference on Jan. 11, 2017 in San Francisco.
MORE ON THIS TOPIC